The World Health Organization (WHO) on Wednesday said it has set up a hub in South Korea to train low- and middle-income countries to produce their own vaccines and therapies and is expanding its COVID-19 vaccine project to further five nations.
The new training hub comes after the UN agency set up a technology transfer hub in Cape Town, South Africa, last year to give companies from poor and middle-income countries the know-how to produce COVID-19 vaccines based on mRNA technology.
The new hub will provide workforce training to all countries wishing to produce products such as vaccines, insulin, monoclonal antibodies, the WHO director general Tedros Adhanom Ghebreyesus said during a press briefing.
The WHO also said five more countries - Bangladesh, Indonesia, Pakistan, Serbia and Vietnam - will receive support from its mRNA technology transfer hub in South Africa.
Last week, six African countries - Egypt, Kenya, Nigeria, Senegal, South Africa and Tunisia - signed up as the first on the continent to receive the technology to manufacture mRNA vaccines at scale and according to international standards.
On Wednesday, Tedros said so far 20 countries had expressed interest in getting training on developing an mRNA vaccine by the South African hub.
WHO launches pandemic data hub in BerlinThe World Health Organization on Wednesday launched a global data hub in Berlin to analyze information on emerging pandemic threats, filling the gaps ... Coronavirus
South Africa, France plan Africa’s first mRNA COVID-19 vaccine facility with WHOSouth Africa, France and the World Health Organization are set to announce plans for Africa’s first COVID-19 vaccine facility using messenger RNA, the ... Coronavirus
COVAX’s supply of COVID-19 vaccines outweighs demand for first timeThe global project to share COVID-19 vaccines is struggling to place more than 300 million doses in the latest sign the problem with vaccinating the ... Coronavirus
Pfizer set to oust AstraZeneca as top supplier of COVID-19 vaccines to poor nationsPfizer and BioNtech are set to displace AstraZeneca as the main suppliers of COVID-19 vaccines to the global COVAX program at the start of 2022, a ... Coronavirus